0000950123-22-008866.txt : 20220812
0000950123-22-008866.hdr.sgml : 20220812
20220812164926
ACCESSION NUMBER: 0000950123-22-008866
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220630
FILED AS OF DATE: 20220812
DATE AS OF CHANGE: 20220812
EFFECTIVENESS DATE: 20220812
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Column Group LLC
CENTRAL INDEX KEY: 0001833486
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20797
FILM NUMBER: 221160882
BUSINESS ADDRESS:
STREET 1: LETTERMAN DRIVE, BUILDING D, SUITE M-900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94129
BUSINESS PHONE: 415-865-2050
MAIL ADDRESS:
STREET 1: LETTERMAN DRIVE, BUILDING D, SUITE M-900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94129
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001833486
XXXXXXXX
06-30-2022
06-30-2022
false
Column Group LLC
Letterman Drive, Building D, Suite M-900
San Francisco
CA
94129
13F HOLDINGS REPORT
028-20797
Y
Certain shares holdings that are reported on this 13F were previously reported on a 13F filed by Peter Svennilson (CIK: 0001606074) (File No. 028-16412)
James Evangelista
Chief Financial Officer
(415) 865-2050
/s/ James Evangelista
San Francisco
CA
08-12-2022
0
7
469864
false
INFORMATION TABLE
2
16275.xml
INFORMATION TABLE FOR FORM 13F
Tenaya Therapeutics, Inc.
COM
87990A106
52924
9400290
SH
SOLE
9400290
0
0
Revolution Medicines Inc
COM
76155X100
85660
4395050
SH
SOLE
4395050
0
0
RAPT Therapeutics Inc
COM
75382E109
48918
2680458
SH
SOLE
2680458
0
0
ORIC Pharmaceuticals Inc.
COM
68622P109
15985
3568181
SH
SOLE
3568181
0
0
NGM Biopharmaceuticals Inc
COM
62921N105
232513
18136735
SH
SOLE
18136735
0
0
Surrozen, Inc.
COM
86889P109
27745
9248129
SH
SOLE
9248129
0
0
eFFECTOR Therapeutics Inc
COM
28202V108
6119
4309329
SH
SOLE
4309329
0
0